Serum neurofilament light chains: Practical benefits

Special report | With kind support from: Novartis Pharma GmbH, Nuremberg

Active relapsing multiple sclerosis Serum neurofilament light chains: Practical benefits

Multiple sclerosis (MS) is characterized by inflammatory demyelination and neuroaxonal damage [1, 2]. These processes can lead to irreversible disability [3]. Imaging techniques such as magnetic resonance imaging (MRI) play an important role in monitoring disease activity. In addition to MRI and clinical examinations, the determination of serum neurofilament light chains (sNfL) could help support personalized treatment decisions in patients with active relapsing-remitting multiple sclerosis (RMS) [3–5].